Doctor profile · Federal record
Dr. Daniel Voglewede, M.D.
Urology Physician · El Paso, TX
- NPI 1588636633
- MIPS 95.8 / 100 · 2023
- 20 yrs on file
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
7420 Remcon Cir, Bldg A
El Paso, TX 799123508
(915) 532-8823
fax (915) 532-5909
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- July 1, 2013
- Specialty taxonomy
- 208800000X — NUCC code
- State license (1)
- Texas #G2504
- Medicaid
- TX #135772504
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1588636633. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
8,708
Distinct HCPCS
6
Medicare allowed
$257,782
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 8,160 | 27 | $23 | |
J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg | 216 | 23 | $168 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 172 | 68 | $172 | |
96372 |
Injection of drug or substance under skin or into muscle | 81 | 26 | $14 | |
96402 |
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 58 | 26 | $33 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 21 | 15 | $125 |
In context: peer comparison
Among 5 peers in El Paso Urology Physician, average services per provider: 211. This provider delivers 41× the peer median.Open Payments
Industry payments received
All-time total
$14
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Boston Scientific Corporation | 1 | $13.81 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,386
Patients
205
Total drug cost
$14,464,580
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Erleada (Apalutamide) | Brand | 475 | 68 | $7,213,086 |
| Xtandi (Enzalutamide) | Brand | 250 | 35 | $3,532,581 |
| Nubeqa (Darolutamide) | Brand | 209 | 28 | $2,841,488 |
| Orgovyx (Relugolix) | Brand | 158 | 16 | $428,061 |
| Abiraterone Acetate | Generic | 65 | 11 | $103,294 |
| Prednisone | Generic | 63 | 12 | $334 |
| Tamsulosin Hcl | Generic | 57 | 22 | $1,564 |
| Methylprednisolone | Generic | 23 | 0 | $521 |
| Prolia (Denosumab) | Brand | 23 | 13 | $39,368 |
| Yonsa (Abiraterone Acet,Submicronized) | Brand | 22 | 0 | $240,215 |
Frequently asked questions
What is Dr. Daniel Voglewede's medical specialty?
Dr. Daniel Voglewede practices Urology Physician in El Paso, TX.
Where does Dr. Daniel Voglewede practice?
Dr. Daniel Voglewede practices at 7420 Remcon Cir, El Paso, TX 799123508. Office phone: 9155328823.
What is Dr. Daniel Voglewede's NPI?
Dr. Daniel Voglewede's National Provider Identifier (NPI) is 1588636633, issued by NPPES.
What procedures does Dr. Daniel Voglewede commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS J9217); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.